Scientific Board 2020

MIRCEA CIUCA, M.D. 

Global Therapeutic Area Head (Immunology & Neurology/Transplant), in Global Clinical Safety and Pharmacovigilance at CSL Behring 

FERNANDA FERRAZIN

 Former Head of Pharmacovigilance Dept.
- Italian Medicines Agency
 

Scientific Board - PEC
(Pharma Education Center)

GIOVANNI FURLAN,

Pharm.D.
 Safety Risk Lead, Director

Pfizer 

 

 

    VALENTINA MANCINI  

EU QPPV
Shionogi 
 Europe

PATRIZIA ROTUNNO

Pharmacovigilance  Consulting, Drug  Safety  Manager of 

 Phast Consulting

MARCO SARDELLA
Chief Pharmacovigilance Officer 
EU QPPV ADIENNE Pharma &

Biotech, Chairperson for EU PV Congress



speakers 2020 in progress

GLYN BELCHER, M.D. 

CEO of PV Consultancy Ltd

 

 

 

 

 

 

D'ANTUONO MARGHERITA, PharmD, PhD

Corporate  PV Director,  EU QPPV

Italfarmaco 

 

 

SARAH HALL,
PhD

HonFPIPA,Managing Director MIPSOL

FABIO DE  GREGORIO
Vice President, Head of Drug Safety Europe,
Shionogi Europe
  

 

HERVE' LE LOUET, M.D., PhD
President of CIOMS, member of PRAC

LAURA BOGA

QPPV - Dompé Pharmaceutical Spa

 

 

 

 

 

 

 

  PAOLA KRUGER

Expert Patient

EUPATI (European Patient's Academy for Therapeutic Innovation) 

 

CALIN A. LUNGU, M.D. 

MRQA, BCPM, Eudravigilance and XEVMPD-EMA, CEO-DDCS

GIAN NICOLA CASTIGLIONE,
M.D.

EU QPPV & Director Global  PV - Chiesi Farmaceutici 

 

 

 

 

PHILLIP EICHORN, M.D.

 Senior Director Worldwide Safety & Regulatory - Pfizer Pharmaceuticals 

  

ARDUINO MANGONI,

MBBS, MD (Hons), PhD
Professor and Head, Department of Clinical Pharmacology,

School of Medicine, Flinders University, Australia

DAVID T CHONZI, M.D. 
  Vice President, Head of PV and Epidemiology, Allogene Therapeutics

 

 

 

DANIELA MARCOZZI 

Head of QA
GCP & GVP
Fidia Farmaceutici

ILARIA GRISONI
Sr. Director,
EEA QPPV
Jazz Pharmaceutical
 

 

 


NELE MATTHIJS 

PV Inspector-DG Inspection - FAMHP - Federal Agency for Medicines and Health Products, Brussels Area, Belgium 

GIOVANNI

NAVALESI,

M.D.

Scientific director at PHARM D&S 

JOSE' ALBERTO

AJALA ORTIZ

PVpharm CEO, EU QPPV, 

PV Consultant,

LCPPV Services

Spain 

PAOLA

PIROVANO

Head of Drug Safety & QPPV Recordati 

 FRANCOISE DUMAS SILLAN, M.D. 

Vice President, Head Global QPPV office at Pfizer 

DORIS IRENE STENVER,
D.M.,MPA
Indep. PV Adviser Founder of Unique Advice, former Chief Medical Officer Danish Medicines Agency and former member of PRAC


 MARCO

TUCCORI

Drug Safety Manager at University Hospital of Pisa

 ALESSANDRA TRAVERSA

Independent Pharmacovigilance Expert 

BERT VAN LEEUWEN, M.D.

Deputy-QPPV of Astellas Pharma

ANNA RUTH VAN TROOSTENBURG DE  BRUYN  

 tGP MD(Lond) FFPM,EU QPPV & VP, Pharmacovigilance & Epidemiology,

Gilead Sciences

MICHAEL  VON FORSTNER 

 Executive Expert in Pharmacovigilance and Pharmaepidemiology